In line with these findings, Zou et al., demonstrated that the low CD8 + methylation TIL score (enriched CD8 + TILs) predicted better survival in colorectal cancer cohorts [45], reinforcing the concept that the methylation pattern may offer opportunities to model tumor immune compartment. The gene discussed is CD8A; the disease is neoplasm.